Schwaneke Jeffrey A.

Average Profitability
<0.0001%
Insider Buys Quantity
1
Insider Buys Sum
$250,206.00
Insider Sells Quantity
13
Insider Sells Sum
$5.99M

Insider Activity of Schwaneke Jeffrey A.

According to the SEC Form 4 filings, Schwaneke Jeffrey A., being in a position of

  1. director at agilon health, inc.,
    оver the last 12 months, has bought 22300 shares for $250,206, and sold 0 shares,
    over all time since 2023-11-29, has bought 22300 shares for $250,206, and sold 0 shares.

The largest purchase of all time was on 2023-11-29 and amounted to 22300 shares of agilon health, inc. for $250,206.

The largest sale of all time was on 2021-05-07 and amounted to 36000 shares of Centene Corporation for $2.48M.

Biography of Schwaneke Jeffrey A.

No biography is available at this moment.

2023-11-29Purchaseagilon health, inc.
AGL
director
22,300
0.0057%
$11.22$250,206-46.35%
2021-05-07SaleCentene Corporation
CNC
EVP, HealthCare Enterprises
36,000
0.006%
$69.00$2.48M+4.88%
2020-04-09SaleCentene Corporation
CNC
EVP, CFO
15,000
0.0027%
$68.00$1.02M-4.32%
2019-01-15SaleCentene Corporation
CNC
EVP, CFO
8,000
0.0039%
$125.00$1M-13.39%
2017-03-13SaleCentene Corporation
CNC
EVP, CFO
4,000
0.0023%
$68.52$274,080+29.71%
2015-12-22SaleCentene Corporation
CNC
EVP, CFO
2,000
0.0017%
$65.09$130,180-4.37%
2014-12-16SaleCentene Corporation
CNC
EVP, CFO
5,000
0.0086%
$101.80$509,000+24.1%
2014-09-09SaleCentene Corporation
CNC
EVP, CFO
1,000
0.0017%
$79.51$79,510+56.08%
2014-08-28SaleCentene Corporation
CNC
EVP, CFO
1,000
0.0017%
$77.02$77,020+58.88%
2013-07-25SaleCentene Corporation
CNC
EVP, CFO
3,000
0.0017%
$17.38$52,140+7.35%
2013-05-30SaleCentene Corporation
CNC
EVP, CFO
3,000
0.0054%
$50.68$152,040+15.99%
2012-12-12SaleCentene Corporation
CNC
EVP, CFO
3,000
0.0022%
$17.38$52,140+12.64%
2011-07-28SaleCentene Corporation
CNC
EVP, CFO
3,000
0.0029%
$17.38$52,140+3.58%
2011-02-25SaleCentene Corporation
CNC
EVP, CFO
6,000
0.0069%
$17.38$104,280+13.58%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.